Major bleeding events by anticoagulant therapy
| Heparin (n/total (%)) | Bivalirudin (n/total (%)) | Significant | |
|---|---|---|---|
| All | 113/3080 (3.7) | 30/1464 (2.1) | 0.003 |
| GPI | 33/1833 (1.8) | 24/1412 (1.7) | 0.80 |
| No GPI | 77/1328 (5.8) | 6/122 (4.9) | 0.12 |
GIP, glycoprotein IIb/IIIa inhibitor.